Drug Eluting Catheter

Drug eluting catheter uses a drug-coated balloon to re-open blocked or narrowed arteries in the thigh and knee due to peripheral artery disease (PAD). The balloon is coated on its outer surface with paclitaxel, a drug which may help stop the arteries from narrowing again (restenosis).

Drug Eluting PTCA Balloon Description

Drug Eluting PTCA Balloon uses a drug-coated balloon to re-open blocked or narrowed arteries in the thigh and knee due to peripheral artery disease (PAD). The balloon is coated on its outer surface with paclitaxel, a drug which may help stop the arteries from narrowing again (restenosis).

PACLITAXEL ELUTING PTCA BALLOON CATHETER

Innovative drug coating technology

Realizes effective release and absorption of paclitaxel;
Nano-needle crystal coating storage of drugs;
Nanosized crystals greatly reduce the probability of distal vascular microembolism, further ensuring safety.

How Drug Eluting PTCA Balloon does it work?

A traditional angioplasty balloon catheter is inserted through the blood vessels, across the blockage or narrowing, and inflated to partially open the blockage or narrowing. The Ranger DCB is then used to fully open the narrowed portion of the artery and apply the drug to the artery wall.

The Ranger DCB is used when arteries in the thigh and knee are narrowed or blocked as a result of peripheral artery disease (PAD). PAD occurs when fatty material (plaque) builds up in these arteries, which can cause hardening and/or narrowing of the arteries (atherosclerosis), limiting the flow of oxygen-rich blood to the body. People with PAD may experience lifestyle-limiting symptoms, such as leg pain, or serious complications, including skin ulcers, or gangrene.